RANDOMIZED CLINICAL-TRIAL OF 13-CIS RETINOIC ACID WITH OR WITHOUT RECOMBINANT-HUMAN-ERYTHROPOIETIN IN MYELODYSPLASTIC SYNDROME PATIENTS WITH PROGRESSIVE OR TRANSFUSION-DEPENDENT ANEMIAS
Ec. Besa et al., RANDOMIZED CLINICAL-TRIAL OF 13-CIS RETINOIC ACID WITH OR WITHOUT RECOMBINANT-HUMAN-ERYTHROPOIETIN IN MYELODYSPLASTIC SYNDROME PATIENTS WITH PROGRESSIVE OR TRANSFUSION-DEPENDENT ANEMIAS, Blood, 84(10), 1994, pp. 10000317-10000317